Ambroxol reverses tau and a-synuclein accumulation in a cholinergic N370S GBA1 mutation model. (2022)
Attributed to:
JPND GBA - personalised medicine for Parkinson disease: clinical and therapeutic stratification
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/hmg/ddac038
PubMed Identifier: 35179198
Publication URI: http://europepmc.org/abstract/MED/35179198
Type: Journal Article/Review
Volume: 31
Parent Publication: Human molecular genetics
Issue: 14
ISSN: 0964-6906